Ms. Raines served as Chief Financial Officer of IDEXX Laboratories, Inc. from October 2003 until her retirement in May 2013, and as Executive Vice President of IDEXX from July 2012 to May 2013, having earlier held positions including Corporate Vice President of Finance, Treasurer and Controller. She currently serves on the boards of TransMedics Group, Inc. (since January 2021) and Ocular Therapeutix, Inc. (since September 2021). She previously served on the boards of Aratana Therapeutics, Inc. (2014 until its acquisition in 2019) and Benchmark Electronics, Inc. (2018 to 2021).
Where the filing does not disclose a value, this page states "Not disclosed" rather than estimating. Smaller filers are exempt from disclosing metric targets and achievement, and larger filers may omit forward targets for competitive reasons.